Edition:
United Kingdom

Torrent Pharmaceuticals Ltd (TORP.NS)

TORP.NS on National Stock Exchange of India

1,779.85INR
11:26am BST
Change (% chg)

Rs-26.30 (-1.46%)
Prev Close
Rs1,806.15
Open
Rs1,800.00
Day's High
Rs1,800.00
Day's Low
Rs1,773.00
Volume
158,186
Avg. Vol
229,208
52-wk High
Rs1,962.00
52-wk Low
Rs1,303.55

Latest Key Developments (Source: Significant Developments)

Torrent Pharmaceuticals Wins Tentative U.S. FDA Approval For Febuxostat - FDA Website
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - FDA Website ::TORRENT PHARMACEUTICALS WINS TENTATIVE U.S. FDA APPROVAL FOR FEBUXOSTAT - FDA WEBSITE.  Full Article

FDA Says Torrent Pharmaceuticals Issues Nationwide Recall Of Losartan Potassium Tablets, Usp
Thursday, 20 Dec 2018 

Dec 20 (Reuters) - U.S. Food And Drug Administration::TORRENT PHARMACEUTICALS LIMITED ISSUES VOLUNTARY NATIONWIDE RECALL OF LOSARTAN POTASSIUM TABLETS, USP.SAYS TORRENT PHARMACEUTICALS HAS NOT GOT ANY REPORTS OF ADVERSE EVENTS RELATED TO RECALL.SAYS TORRENT RECALLING 2 LOTS OF LOSARTAN POTASSIUM TABLETS, USP DUE TO TRACE AMOUNTS OF UNEXPECTED IMPURITY IN API MANUFACTURED BY HETERO LABS.  Full Article

Torrent Pharmaceuticals Dec-qtr Net Profit Plunges 75 Pct
Thursday, 8 Feb 2018 

Feb 8 (Reuters) - Torrent Pharmaceuticals Ltd ::APPROVED INTERIM DIVIDEND OF 9 RUPEES PER SHARE.DEC QUARTER CONSOL NET PROFIT 580 MILLION RUPEES VERSUS PROFIT OF 2.29 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL NET PROFIT WAS 2.20 BILLION RUPEES.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 14.77 BILLION RUPEES VERSUS 14.43 BILLION RUPEES LAST YEAR.  Full Article

‍Torrent Pharma buys branded business of India & Nepal from Unichem
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Torrent Pharmaceuticals Ltd ::‍Torrent Pharma acquires branded formulation business of India and Nepal of Unichem Laboratories Limited​.Says deal for 36 billion rupees‍​.Says will fund deal through mix of internal accruals, bank borrowings‍​.Says deal is ongoing concern basis by way of slump sale.Says about 3000 plus employess will get added to Torrent's existing employee pool.Deal is expected to close by end of 2017‍​.  Full Article

India's Torrent Pharmaceuticals Sept-qtr consol profit down 1.4 pct
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Torrent Pharmaceuticals Ltd ::Sept quarter consol net profit 2.04 billion rupees versus profit of 2.07 billion rupees last year.Consensus forecast for Sept quarter consol net profit was 2.17 billion rupees.Sept quarter consol net sales 14.01 billion rupees versus 14.06 billion rupees last year.  Full Article

India's Torrent Pharmaceuticals June-qtr consol profit falls about 36 pct
Monday, 31 Jul 2017 

July 31 (Reuters) - Torrent Pharmaceuticals Ltd ::June quarter consol net profit 1.88 billion rupees versus 2.92 billion rupees last year.Torrent Pharmaceuticals Ltd consensus forecast for June quarter consol net profit was 1.82 billion rupees.June quarter consol total revenue 14.79 billion rupees versus 15.77 billion rupees last year.  Full Article

Torrent Pharma's Indrad plant gets 4 observations from FDA
Friday, 12 May 2017 

May 12 (Reuters) - Torrent Pharmaceuticals Ltd ::Torrent pharmaceuticals clarifes on news item "Torrent pharma gets four U.S. FDA observations for Indrad plant".Torrent pharmaceuticals says USFDA inspectors have carried out audit of our Indrad plant.Torrent pharmaceuticals says received four observations from USFDA inspectors relating to improvement in procedures.  Full Article

UPDATE 3-New cancer-causing toxin found in recalled blood pressure pills

March 1 U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd a day earlier, adding to a global recall of commonly used drugs to treat hypertension.